Drugs / Polyherbal Formulation (PHF)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06846138 | Mar 2025 → Dec 2026 expected | type 2 diabetes mellitus | Pauls Stradins Clinical University Hospital | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyherbal Formulation (PHF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06846138 ↗ |
| Route | Oral | “Administration: Oral, daily dosage as per study protocol.” NCT06846138 ↗ |